Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Med Parazitol (Mosk) ; (1): 48-51, 2014.
Artigo em Russo | MEDLINE | ID: mdl-24738231

RESUMO

The paper describes cases of pseudoinvasion and transient carriageof the larvae of arthropods and geohelminths. It highlights the objective and subjective factors in the diagnosis of arthropod-borne diseases and geohelminthiasis, which give rise to misdiagnosis. Distinctions between real invasion, transient invasion, and pseudoinvasion are pointed out. The fact that there are special problems with the misdiagnosis of people with mental diseases is emphasized. The key factors for preventing and diagnosing pseudoinvasions and transient carriage are defined.


Assuntos
Artrópodes/classificação , Gastroenteropatias/parasitologia , Trato Gastrointestinal/parasitologia , Larva/classificação , Nematoides/isolamento & purificação , Solo/parasitologia , Adulto , Idoso , Animais , Artrópodes/crescimento & desenvolvimento , Feminino , Gastroenteropatias/diagnóstico , Gastroenteropatias/psicologia , Humanos , Larva/crescimento & desenvolvimento , Masculino , Pessoa de Meia-Idade , Nematoides/crescimento & desenvolvimento
2.
Klin Med (Mosk) ; 78(5): 39-42, 2000.
Artigo em Russo | MEDLINE | ID: mdl-10881509

RESUMO

Patients with acute viral hepatitis B, A and mixed hepatitis B + C were treated in two independent clinics with phosphogliv--a new hepatoprotective drug based on polyunsaturated phosphatidylcholine and glycyrrhizic acid salt. Phosphogliv removed some symptoms of intoxication (nausea, weakness, jaundice, etc.) quicker than basic therapy. Among biochemical hepatitis markers, serum bilirubin level was most responsive to phosphogliv. Standard therapy decreases bilirubin by 30% on the average for 5 days, phosphogliv reduces bilirubin for one more week to half those values observed in control patients. At that point low aminotransferase activities were seen in phosphogliv treated patients. No side effects were seen. The new hepatoprotector phosphogliv which repairs biomembranes represents drugs of new generation compared to phospholipid drug essential.


Assuntos
Antivirais/uso terapêutico , Hepatite A/tratamento farmacológico , Hepatite B/complicações , Hepatite B/tratamento farmacológico , Hepatite C/complicações , Hepatite C/tratamento farmacológico , Doença Aguda , Adolescente , Adulto , Humanos , Masculino , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA